Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oxford Biotherapeutics
Biotech
Roche doubles down on ADCs in $1B biobucks pact with Oxford Bio
Roche has secured its third antibody-drug conjugate deal of the year, agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics.
James Waldron
Mar 19, 2025 5:12am
Chutes & Ladders—Gilead’s commercial head to retire
Mar 2, 2018 9:00am
OBT raids Celgene for CMO as I-O trial plan takes shape
Mar 1, 2018 7:49am
Boehringer takes up option on Oxford BioTherapeutics oncology target
Apr 21, 2016 1:38am
